Verapamil v preventivní léčbě cluster headache
| Title in English | Verapamil in the preventative treatment of cluster headache |
|---|---|
| Authors | |
| Year of publication | 2025 |
| Type | Article in Periodical |
| Magazine / Source | Neurologie pro praxi |
| MU Faculty or unit | |
| Citation | |
| web | https://neurologiepropraxi.cz/artkey/neu-202501-0009_verapamil_v_preventivni_lecbe_cluster_headache_den_povedomi_o_cluster_headache_2025.php |
| Doi | https://doi.org/10.36290/neu.2025.001 |
| Keywords | cluster headache; trigeminal autonomic cephalalgias; pain management; therapeutics; calcium channel blockers; verapamil |
| Attached files | |
| Description | Cluster headache is a primary headache disorder classified under trigeminal autonomic cefalalgias. Its treatment is based on empirical recommendations and includes acute, preventative and bridging treatment strategies, and complemented by neuromodulatory methodes. Verapamil is considered first-line preventative medication, although its use in cluster headache is off-label. The treatment should be started at the very beginning of the cluster period with an initial dose of 240 mg/day, prior it is mandatory to rule out contraindications and confirm that patient´s echocardiographic finding is normal. During the first week of treatment, the typical effective therapeutic dose of 360 mg/day is achieved. Further increase of the dose is provided stepwise according the needs of the patient and with routine electrocardiogram monitoring. If high (? 480 mg/day) or very high doses (? 720 mg/day) of verapamil are necessary, treatment should be administered under the specialist´s supervision with close cardiological follow-up. The maximu recommended dose for preventative treatment of cluster headache is 960 mg/day. Preventative treatment usually continues for several weeks or months and must be withdrawn gradually. |
| Related projects: |